Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[rkp72]

Just "having data" is not going to cut it with FDA, because this data was not gathered in a formal FDA-approved IND. If RCP is lucky, FDA may give approval for a Phase1/II combined trial. But getting the "use" patent is the first key step. Then comes financing. It is possible that JH or another research institution might provide this - I hope so. Eventually I see no option but get bought. I hope this comes about at a much higher stock price.